Evaluation of an EEG Based Concussion System

Status Recruiting

Clinical Trial Summary

This study will evaluate the accuracy of a new concussion system at detecting concussions. The investigators will be evaluating the degree to which data collected with the device agrees with a physician's determination of a concussion. The system captures an electroencephalograph (EEG) potential when a light is flashed into the eyes of an individual. The device is not FDA approved, but it is a non-significant risk device. The device is a non-invasive, non-interventional sensor. It will not replace the opinion of the physician in diagnosing a concussion. This study will test the EEG based concussion system on 200 individuals, Participants will be made up of individuals who are seeking medical consultation at the Play Safe Concussion Clinic (10 Union Square E, New York, NY 10003) or at Mount Sinai Hospital (1468 Madison Ave, New York, NY 10029) after experiencing a head trauma. The Play Safe Clinic treats patients who reach out to Mount Sinai Physicians via the Play Safe telephone number: 212 241 2221. The doctors who see patients these locations will be involved in conducting this research. In addition to the standard-of-care clinical assessments, participants will also receive an evaluation from the concussion based system. When a subject experiences a head trauma, the subject will be evaluated for a concussion by both the standard-of-care clinical assessments. The treating physician will provide all necessary standard-of-care evaluations and diagnostic procedures needed to properly diagnose and treat each patient and by the new concussion system. The researchers will also collect data from healthy, age-matched controls in order to collect a database of healthy responses to the technology. To determine how accurate the new concussion system is at detecting concussions, the research team will compare the diagnostic results from the device to the diagnostic results of the doctor's assessments. The goal of this study is to develop a device that can give sound advice as to whether an individual should seek medical attention for a possible concussion following a head injury.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Concussion

Clinical Trial Details

NCT number	NCT03710109
Study type	Observational
Source	Icahn School of Medicine at Mount Sinai
Contact	Aidan Rogers, MS
Phone	212-824-8369
Email	aidan.rogers@mountsinai.org
Status	Recruiting
Phase
Start date	October 23, 2018
Completion date	July 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03304327` - Mindfulness and Yoga Training for Athletes With Concussion (MYTAC)	N/A
Completed	`NCT05562544` - EEG Diagnostic for Repetitive Sub-concussive Head Impacts
Terminated	`NCT02988609` - Concussion in Rugby Players: a Pilot Study of Neural Recovery Using fMRI	N/A
Completed	`NCT02710123` - Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion	N/A
Terminated	`NCT02100150` - A Safety and Efficacy Study of NNZ-2566 in Patients With Mild Traumatic Brain Injury (mTBI)	Phase 2
Active, not recruiting	`NCT01874847` - PLAY GAME: Post-concussion Syndrome in Youth - Assessing the GABAergic Effects of Melatonin	Phase 2/Phase 3
Completed	`NCT02262507` - Concussion Device Audiological Measures	N/A
Completed	`NCT01903525` - DHA For The Treatment of Pediatric Concussion Related to Sports Injury	Phase 1
Enrolling by invitation	`NCT05948501` - The Effects of Concussion on Gait and Posture in Individuals With Peripheral Vision Loss
Withdrawn	`NCT02643836` - Pulsed Electromagnetic Field (PEMF) Therapy for Post-Concussive Syndrome	N/A
Recruiting	`NCT03360786` - Primary Prevention of Concussion in Youth Ice Hockey Players	N/A
Not yet recruiting	`NCT02930395` - Blood Biomarkers for the Management of Concussion in Professional Rugby Players	N/A
Completed	`NCT02278029` - Driving Performance of Teenage Patients With mTBI: a Longitudinal Assessment	N/A
Completed	`NCT02268240` - Care for Post-Concussive Symptoms	N/A
Completed	`NCT02271451` - Q-collar and Brain Injury Biomarkers	N/A
Completed	`NCT02268058` - Use of Ibuprofen and Acetaminophen for Treatment of Acute Headache Post Concussion in Children	N/A
Active, not recruiting	`NCT03608722` - Video Games to Track Cognitive Health	N/A
Completed	`NCT02660164` - A Study to Assess the Effectiveness of the Nautilus BrainPulse™ as an Aid in the Diagnosis of Concussion
Completed	`NCT02556177` - Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2	N/A
Completed	`NCT02344446` - Physical Therapy Intervention for Extended Physical Symptoms After a Sports-related Concussion	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.